This article is only available in the PDF format. Download the PDF to view the article, as well as its associated figures and tables.
To the Editor:—
In The Journal April 1 appeared a letter from Dr. L. Zwillinger of Prostějov, Czechoslovakia, relative to the therapeutic use of magnesium sulfate in paroxysmal tachycardia. I should like to correct a false impression which evidently was created by my informal discussion of Dr. George Fahr's paper. The mere fact as stated that I had successfully used magnesium sulfate in several cases should not have been construed as a claim to priority in its use. In Europe as well as in the United States through The Journal the work of Dr. Zwillinger has been publicized. An editorial "we in Vienna" might have been in better taste, or since the purpose of my brief discussion was merely to remind the audience of the use of magnesium sulfate in tachycardia, the "first person" could and should have been omitted entirely. I am but one of a number of cardiologists
Dressler W. MAGNESIUM SULFATE IN PAROXYSMAL TACHYCARDIA. JAMA. 1939;112(21):2190. doi:10.1001/jama.1939.02800210084025
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: